Lévy V - Search Results

1

A meta-analysis on data from 575 patients with multiple myeloma randomly assigned to either high-dose therapy or conventional therapy.

Lévy V, Katsahian S, Fermand JP, Mary JY, Chevret S. Lévy V, et al. Medicine (Baltimore). 2005 Jul;84(4):250-259. doi: 10.1097/01.md.0000173272.71949.a1. Medicine (Baltimore). 2005. PMID: 16010209 Free article.

2

Evaluating high dose therapy in Multiple Myeloma: use of quality-adjusted survival analysis.

Porcher R, Lévy V, Fermand JP, Katsahian S, Chevret S, Ravaud P. Porcher R, et al. Among authors: levy v. Qual Life Res. 2002 Mar;11(2):91-9. doi: 10.1023/a:1015096313594. Qual Life Res. 2002. PMID: 12018742 Clinical Trial.

3

Sample size correction for treatment crossovers in randomized clinical trials with a survival endpoint.

Porcher R, Lévy V, Chevret S. Porcher R, et al. Among authors: levy v. Control Clin Trials. 2002 Dec;23(6):650-61. doi: 10.1016/s0197-2456(02)00239-8. Control Clin Trials. 2002. PMID: 12505243

4

Factors influencing inclusion of patients with malignancies in clinical trials.

Tournoux C, Katsahian S, Chevret S, Levy V. Tournoux C, et al. Among authors: levy v. Cancer. 2006 Jan 15;106(2):258-70. doi: 10.1002/cncr.21613. Cancer. 2006. PMID: 16397866 Free article. Review.

5

A practical approach for eliciting expert prior beliefs about cancer survival in phase III randomized trial.

Hiance A, Chevret S, Lévy V. Hiance A, et al. Among authors: levy v. J Clin Epidemiol. 2009 Apr;62(4):431-437.e2. doi: 10.1016/j.jclinepi.2008.04.009. Epub 2008 Nov 17. J Clin Epidemiol. 2009. PMID: 19010642

6

How to use clinical vignettes in hematology--a pilot survey in the context of chronic lymphocytic leukemia.

Camps SM, Chevret S, Lévy V. Camps SM, et al. Among authors: levy v. Leuk Res. 2009 Oct;33(10):1328-34. doi: 10.1016/j.leukres.2008.11.008. Epub 2008 Dec 17. Leuk Res. 2009. PMID: 19095303

7

Evaluating treatment strategies in chronic lymphocytic leukemia: use of quality-adjusted survival analysis.

Levy V, Porcher R, Delabarre F, Leporrier M, Cazin B, Chevret S; French Cooperative CLL Group. Levy V, et al. J Clin Epidemiol. 2001 Jul;54(7):747-54. doi: 10.1016/s0895-4356(00)00359-0. J Clin Epidemiol. 2001. PMID: 11438417 Clinical Trial.

8

Evaluating treatment strategies in advanced Waldenström macroglobulinemia: use of quality-adjusted survival analysis.

Lévy V, Porcher R, Leblond V, Fermand JP, Cazin B, Maloisel F, Harousseau JL, Remenieras L, Guibon O, Chevret S; French Cooperative Group on CLL and Macroglobulinemia. Lévy V, et al. Leukemia. 2001 Sep;15(9):1466-70. doi: 10.1038/sj.leu.2402221. Leukemia. 2001. PMID: 11516109 Clinical Trial.

9

Fludarabine plus cyclophosphamide in Waldenström's macroglobulinemia: results in 49 patients.

Tamburini J, Lévy V, Chaleteix C, Fermand JP, Delmer A, Stalniewicz L, Morel P, Dreyfus F, Grange MJ, Christian B, Choquet S, Leblond V. Tamburini J, et al. Among authors: levy v. Leukemia. 2005 Oct;19(10):1831-4. doi: 10.1038/sj.leu.2403885. Leukemia. 2005. PMID: 16121217

10

Quality assessment of phase I dose-finding cancer trials: proposal of a checklist.

Zohar S, Lian Q, Levy V, Cheung K, Ivanova A, Chevret S. Zohar S, et al. Among authors: levy v. Clin Trials. 2008;5(5):478-85. doi: 10.1177/1740774508096653. Clin Trials. 2008. PMID: 18827040 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

468 results

Search Page

Filters